Search

for
Search:

Research

5 / 1000+ results

April 2025 in “International Journal of Dermatology”

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

January 2024 in “Journal of Crohn's and colitis”

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

June 2023 in “Fundamental & clinical pharmacology”

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

January 2024 in “Wiadomości Lekarskie”

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

November 2005 in “Reactions Weekly”

A man treated with gefitinib for lung cancer grew new hair on his bald scalp.

2 / 801 results

a JAK inhibitor for alopecia areata and other autoimmune conditions

JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases

— no results

— no results

— no results